Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function

European Heart Journal

Volumn 20, Issue 8, 1999, Pages 567-574

  Verheggen, P W H M ^a   De Maat, M P M ^b   Manger Cats, V ^a   Haverkate, F ^b   Zwinderman, A H ^c   Kluft, C ^b   Bruschke, A V G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

^c Department of Medical Statistics ^*  (Netherlands)

Author keywords

Coagulation; Coronary artery disease; Inflammation; Prognosis; Unstable angina

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOTTING; BODY MASS; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DISEASE COURSE; ENDOTHELIUM CELL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART MUSCLE NECROSIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SMOKING; STATISTICAL ANALYSIS; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0032890971     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1312     Document Type: Article

References (43)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes: Part 1 and 2. N Engl J Med. 326:1992;242-50
2. Chesebro JH, Fuster V. Thrombosis in unstable angina. N Engl J Med. 327:1992;192-194.
3. Maseri A. Ischemic heart disease. 1995;Churchill Livingstone, New York.
4. Muhlestein JB, Hammond EH, Carlquist JF. Increased incidence of Chlamydia Species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 27:1996;1555-1561.
5. Saikku P. Chlamydia pneumoniae. Eur Heart J. 14:1993;62-65.
6. Linnanmaki E, Leinonen M, Matilla K, Nieminen MS, Viltonen V, Saikku P. Chlamydia pneumoniae. Circulation. 87:1993;1130-1134.
7. van der Wal AC, Becker AE, van de Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterised by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:1994;36-44.
8. Sato T, Takebayashi S, Kohchi K. Increased subendothelial infiltration of the coronary arteries with monocytes/macrophages in patients with unstable angina: Histological data on 14 autopsied patients. Atherosclerosis. 68:1987;191-197.
9. Kohchi K, Takebayashi S, Hiroki T, Nobuyoshi M. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation. 71:1985;709-716.
10. Neri Serneri GG, Abbate R, Gori AM. A transient intermittent lymphocyte activation is responsible for the unstability of angina. Circulation. 86:1992;790-797.
11. Mazzone A, de Servi B, Ricevuti G. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation. 88:1993;358-363.
12. Moreno PR, Falk E, Palacios IF, Nervell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implication for plaque rupture. Circulation. 90:1994;775-778.
13. Moreno PR, Bernardi VH, Lopez-Cuellar J. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Circulation. 94:1996;3090-3097.
14. Neri Serneri GG, Prisco D, Martini F. Acute T-cell activation is detectable in unstable angina. Circulation. 95:1997;1806-1812.
15. Merlini PA, Bauer KA, Oltrona L. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation. 90:1994;61-68.
16. Ardissino D, Merlini PA, Gamba G. Thrombin activity and early outcome in unstable angina pectoris. Circulation. 93:1996;1634-1639.
17. Ardissino D, Gamba MG, Merlini PA. Fibrinopeptide A excretion in urine: a marker of the cumulative thrombin activity in stable versus unstable angina patients. Am J Cardiol. 68:1991;58B-63B.
18. Jude B, Agraou B, McFadden EP. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation. 90:1994;1662-1668.
19. Meade TW. Fibrinogen in ischemic heart disease. Eur Heart J. 16:1995;31-35.
20. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive Protein in 'active' coronary artery disease. Am J Cardiol. 65:1990;168-172.
21. Liuzzo G, Biasucci LM, Gallimore JR. The prognostic value of C-Reactive Protein and Serum Amyloid A Protein in severe unstable angina. N Engl J Med. 331:1994;417-424.
22. Biasucci LM, Vitelli A, Liuzzo G. Elevated levels of interleukin-6 in unstable angina. Circulation. 94:1996;874-877.
23. Becker RC, Cannon CP, Bovill EG. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction. Am J Cardiol. 78:1996;142-147.
24. Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation. 96:1997;4204-4210.
25. Bottiger L, Carlson LA. Risk factors for ischemic vascular death for men in the Stockholm Prospective study. Atherosclerosis. 36:1980;389-408.
26. Gillum RF, Mussolino ME, Makuc DM. Erythrocyte sedimentation rate and coronary heart disease: the NHANES I epidemiologic follow-up study. J Clin Epidemiol. 48:1995;353-361.
27. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo J. Hemostatics factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 332:1995;635-641.
28. Kuller LH, Tracey RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 144:1996;537-547.
29. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 349:1997;462-466.
30. Ridker PM, Cushman M, Stampfer MJ, Tracey RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979.
31. Oltrona L, Ardissino D, Merlini P, Spinola A, Chiodo F, Pezzano A. C-reactive protein elevation and early outcome in patients with unstable angina pectoris. Am J Cardiol. 80:1997;1002-1006.
32. Von Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol. 17:1957;237-246.
33. Astrup T, Brakman P, Nissen U. The estimation of fibrinogen. A revision. Scan J Clin Invest. 17:1965;57-65.
34. Verheijen JH, Chang GTG, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemost. 51:1984;392-395.
35. Donelly R, Hillis WS. Cardiac troponin T. Lancet. 341:1993;410-411.
36. Ikeda U, Ohkawa F, Seino Y. Serum interleukin-6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol. 24:1992;579-584.
37. Miyao Y, Yasue H, Ogawa H. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J. 126:1993;1299-1304.
38. Panniteri G, Marino B, Campa PP, Martucci R, Testa U, Peschle C. Interleukin 6 and 8 as mediators of acute phase response in acute myocardial infarction. Am J Cardiol. 80:1997;622-625.
39. Neumann F-J, Ott I, Gawaz M. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 92:1995;748-755.
40. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
41. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to induce tissue factor. Blood. 82:1993;513-520.
42. Pepys MB, Rowe IF, Baltz ML. C-reactive protein: binding to lipids and lipoproteins. Int Rev Exp Pathol. 27:1985;83-111.
43. Volanakis JE. Complement activation by C-reactive protein complexes. Ann N Y Acad Sci. 389:1982;235-250.